Developing a Risk Management Plan in Pharmacovigilance

A Risk Management Plan Pharmacovigilance (RMP) is a document that describes the safety profile of a medicine and the measures used to prevent or minimize risks to patients. Whether you are submitting to the US FDA (as a REMS) or the EMA, the RMP is a mandatory part of the dossier.

Core Objectives of the RMP

The primary goal of a Risk Management Plan Pharmacovigilance is to:

• Identify or characterize the safety profile of the medicinal product.

• Indicate how to further characterize the safety profile.

• Document measures to prevent or minimize the risks associated with the product.

The Global Landscape: FDA vs EMA

While the core goal remains the same, the format for a Risk Management Plan Pharmacovigilance varies. The EU RMP format is highly standardized under GVP Module V, whereas the US uses the Risk Evaluation and Mitigation Strategies (REMS) framework for high-risk products.